G + Flas Life Sciences

Developing gene editing technologies for new drugs and plant-based biopharmaceuticals

placeCheongju-si, Chungcheongbuk-do, South Korea calendar_todayFounded 2014 groups9 employees language gflas.com

Registered entities

Social engagement

Social engagement: 162 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Smile Gate Investment, Chong Kun Dang Pharmaceutical, Alpen Route, ActnerLab.

Investor typeCountShare
Private equity360%
Accelerator & incubator120%
Other / undisclosed120%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

19 Feb 2026 · Business Development Executive · Seoul

Based on job postings tracked across public sources.

Coming soon